Physician profile
Edgar Solis
NPI 1285798181
$1,389.68
in general payments reported to CMS, 2019-2025
12 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $16.81 · 2021: $130 · 2022: $254 · 2023: $88.87 · 2024: $300 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.35 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $299.86 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $273.22 | 2022-2024 | |
| Greenwich Biosciences, INC. | $237.57 | 2019-2021 | |
| Immedica Pharma US, INC. | $127.25 | 2024 | |
| United Therapeutics Corporation | $116.07 | 2025 | |
| Ucb, INC. | $108.80 | 2022 | |
| Harmony Biosciences LLC | $104.99 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.00 | 2021-2022 | |
| Neurelis, INC. | $33.16 | 2024 | |
| Shire North American Group INC | $20.00 | 2019 | |
| Johnson and Johnson International | $16.81 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.